老年骨质疏松细胞病理特点与治疗思考
Characteristics of cellular pathology and consideration of treatment in osteoporosis of the elderly
出处
《老年医学与保健》
CAS
2003年第2期68-71,共4页
Geriatrics & Health Care
参考文献14
-
1王淑萍,宋新德.维生素D与骨质疏松概述[J].中国骨质疏松杂志,2000,6(1):10-13. 被引量：6
-
2费琴明,崔大敷,陈统一,陈中伟.合成成骨生长肽的体内外成骨活性[J].生物化学与生物物理学报,2001,33(4):415-420. 被引量：33
-
3王洪复,金慰芳,高建军,顾淑珠,周轶,孙爱龙,胡菲,沈洁,张顺昌.重组人甲状旁腺激素_(1-34)对去卵巢大鼠骨质疏松的治疗作用[J].中国医学科学院学报,2003,25(3):275-279. 被引量：25
-
4盛辉,王洪复,高建军,金慰芳,顾淑珠.不同浓度地塞米松诱导大鼠间充质干细胞向成骨细胞的分化[J].复旦学报（医学版）,2003,30(2):164-166. 被引量：13
-
5朱国英,王洪复,徐培康,徐爱红.绝经后妇女骨丢失与1,25-二羟维生素D的相关性研究[J].中华医学杂志,2001,81(23):1443-1446. 被引量：13
-
6Raisz LG. Physiology of Bone. In Becker KL(ed): Principles and Practice of Endocrinology and Metabolism, 3rded, Philadephia, J.B. Lippincott, 2001, 489-497.
-
7Wang L, Banu J, McMahan CA, et al. Male rodent model of agerelated bone loss in men. Bone, 2001, 29(2): 141 - 148.
-
8Ke HZ, Qi H, Chidsey- Frink KL, Crawford DT, et al. Lasofoxirene (CP - 336, 156) protects against the age - related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats. J Bone Miner Res, 2001, 16(4): 765 -773.
-
9Caplan AI. The mesengenic process. Clin Plast Surg, 1994, 21 (3):429 - 435.
-
10D" lppolito G, Schiller PC, Ricordi C, et al. Age - related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res, 1999, 14(7): 1115 - 1122.
二级参考文献25
-
1朱文菁,金慰芳,张丽丽,张罗修,王洪复.MTT法分析培养成骨细胞的存活和增殖能力[J].上海医科大学学报,1995,22(4):254-257. 被引量：79
-
2Silverberg SJ, Shane E, de la Cruz L, et al. Skeletal disease in Primary hyperparathyroidism. J Bone Miner Res,1989, 4:281-291.
-
3Rubin Mr, Cosman F, Lindsay IL et al. The anabolic effects of parathyroid hormone. Osteoporos Int, 2002, 13:267-277.
-
4Ejersed C, Andeassen TF, Hauge EM, et al. Parathyroid bormone(1-34) increases vertebral bone mass, compressive strength, and quality in old rats. Bone, 1995, 17(6):507-511.
-
5Sato M, Vahle J, Schmidt A, et al. Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH. Endocrinology, 2002, 143:3230-3242.
-
6Okimoto N, Tsurukami H, Okazaki Y, et al. Effects of a weekly injection of human parathyroid hormone(1-34) and withdrawal on bone mass, stxength, and tumover in mature ovariectomized rats. Bone, 1998, 22:523-531.
-
7Brommage R, Hotchkiss CE, Lces CJ, et al. Daily treatment with human recombinant parathyroid hormone(1-34) LY333334,for l year increases bone mass in ovariectomized monkeys.J Clin Endocrinol Metab, 1999. 84(10):3757-3763.
-
8Sato M, Weatmore M, Clendenon J, et al. Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumber vertebrate of ovariectomized cynomolgus macaques. Osteoporm lnt, 2000, 11(10):871-880.
-
9Ma YL, Cain RI, Helladay DL, et al. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology,2001, 142:4047-4054.
-
10Locklin RM, Khosla S, Riggs BL. Mechanism of biphasic and catabolic effects of parathyroid hormone(PTH) on bone cells. Bone, 2001, 28 (Suppl):580.
共引文献85
-
1董芒艳,董进.骨质疏松症的非性激素药物治疗新进展[J].基层医学论坛,2008,12(28):943-944. 被引量：1
-
2滕立臣,赵宝权,刘兴汉,余琼,宋大勇.重组成骨生长肽对同种异体骨移植愈合的实验研究[J].哈尔滨医科大学学报,2004,38(3):225-228. 被引量：4
-
3阮峰,肖德明.PTH治疗骨质疏松症的研究进展[J].中国骨肿瘤骨病,2004,3(5):268-272. 被引量：4
-
4张颖,彭永德.骨质疏松症治疗新药特立帕肽[J].世界临床药物,2004,25(12):725-729. 被引量：8
-
5光学期刊发展与合作研讨会在上海举行[J].中国激光,2004,31(12):1522-1522. 被引量：1
-
6邵云潮,王伟光,陈红红,程文英,崔大敷,陈统一,陈中伟.成骨生长肽促进实验性再生障碍性贫血小鼠造血的恢复[J].复旦学报（医学版）,2005,32(1):1-4. 被引量：1
-
7丰盛梅,高建军,金慰芳.PTH作用于老年大鼠骨髓细胞骨代谢相关基因表达的实验方法[J].复旦学报（医学版）,2005,32(2):219-221. 被引量：6
-
8张文贤,张晓刚.成骨生长肽的研究进展[J].中国骨伤,2005,18(3):190-191. 被引量：4
-
9金慰芳,王洪复,高建军,徐培康,徐爱红,骆宏丰,胡昌奇.锦鸡儿有效成分对卵巢摘除大鼠骨质疏松的防治作用[J].复旦学报（医学版）,2005,32(3):305-308. 被引量：4
-
10林冬云,黄晓南,柯李晶,陈晓超,叶秀云,霍玉书,饶平凡.鹿茸中促大鼠成骨样细胞增殖活性组分的纯化与表征[J].中国中药杂志,2005,30(11):851-855. 被引量：10
-
1郑林,肖涟波.鲑鱼降钙素治疗骨质疏松症的临床应用进展[J].风湿病与关节炎,2014,3(10):64-66. 被引量：15
-
2张以文.破骨细胞骨吸收的机制[J].中国骨质疏松杂志,1996,2(1):49-50. 被引量：1
-
3于明香,王洪复.降钙素对破骨细胞骨吸收抑制作用的机理[J].中华内分泌代谢杂志,1997,13(2):119-122. 被引量：10
-
4改变对骨质疏松的看法[J].英国医学杂志中文版,2001,4(1):49-51. 被引量：4
-
5邱贵兴,裴福兴,胡侦明,唐佩福,薛庆云,杨惠林,陶天遵,赵宇.中国骨质疏松性骨折诊疗指南(全文)(骨质疏松性骨折诊断及治疗原则)[J].中华关节外科杂志（电子版）,2015,9(6):96-99. 被引量：180
-
6宋家政.激素性股骨头坏死患者外周血OST、CTX的表达及临床意义[J].中国实验诊断学,2016,20(11):1929-1930. 被引量：7
-
7盛志峰,陈瑜,廖二元.骨质疏松治疗促骨形成与抗骨吸收药物序贯或联合应用[J].中华骨质疏松和骨矿盐疾病杂志,2015,8(3):267-271. 被引量：6
-
8林华.降钙素在骨质疏松骨折治疗中的应用[J].中国骨与关节杂志,2014,3(4):317-320. 被引量：3
-
9王洪复,朱国英.重视老年骨质疏松症的骨形成促进治疗[J].老年医学与保健,2015,21(1):11-14. 被引量：2
-
10盛辉.单纯补钙治不了骨质疏松症[J].家庭医学（上半月）,2015,0(6):28-29.
